Moreover, Rap1GAP-overexpressing pancreatic cancer cells treated with apoptosis-inducing chemotherapeutic drugs, such as 5-FU and etoposide, induced up to 28% (5-FU) and 13% (etoposide) higher rates of apoptosis in comparison to control cells. Here, RAP1GAP is linked to familial pancreatic carcinoma.